🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Glad to share our outcomes with a novel regimen(ddDCEP) from CMC Vellore, with a very encouraging pCR(55.2%) in high-risk early and locally advanced TNBC. The poster is online at the ESMO Virtual Congress 2020 #ESMO2020 @MyESMO Ashish Singh, Anjana Joel, Divya Thumaty, Raju Chacko

Here’s to the women who have taken over the world. What keeps their spirit unwavered? Being a rebel. It's time to let the rebel in you take over 🔥 #TRebelWithboAt #IAmARebel

#cisplatin added to NACT(AC-TP) was tolerable and resulted in high PCR in our patients with locally advanced #tnbc #breastcancer Jame Abraham, MD, FACP Anand D Jeyasekharan Ashish Singh Raju Chacko Anjana Joel Divya Thumaty Ajoy Oommen John pubmed.ncbi.nlm.nih.gov/33657819/

Chat with Eby the-sparrowsnest.net/2021/03/08/cha…

Ability to pay for a treatment will create a bigger health disparity than non-availability of a treatment in your country. #HealthForAll #globalhealth

meetinglibrary.asco.org/record/196389/… Even before we begin using CPI for eTNBC in resource limited settings.. GeparNUEVO questions the science behind the use and duration of post operative adjuvant CPI treatment in eTNBC.. #ASCO2021 #Oncoalert

I couldn't believe my eyes. So I asked my colleague to read to me the recent Covid19 guidelines by DGHS Ministry of Health. I couldn't believe my ears too. The 9-page-PDF guides how to treat, investigate and monitor patients with Covid19 infection. What is the first surprise? 1/N

Great tweetorial explaining the findings of this intriguing study!

इसका जलवा जारी है ये हिंदुस्तानी नारी है!! ⁦Harleen Kaur Deol⁩ #IndWomenvsEngWomen

tandfonline.com/eprint/PFU5Y5R… ESOncology ESMO - Eur. Oncology ESMO Open ESGO Gynecologic Cancer Initiative ISMPO Ind J Med Ped Oncology Josh Thomas Georgy Anjana Joel Ajoy Oommen John Young Oncologists Group India🇮🇳

Wow - impressive EFS benefit of adding carboplatin to NACT for TNBC in #BrighTNess trial! 👉4-year EFS was 79% with carbo vs 68% w/o (HR 0.57, p=0.02) Just released by ESMO - Eur. Oncology Daily Reporter, these data will be presented by S.Loibl on 17 Sept @ #ESMO21 dailyreporter.esmo.org/esmo-congress-…

Posted as received: This poignant photo is the work of an Afghan artist named Shamsia Hassani, 33 years old, Afghan graffiti artist and teacher at Kabul University If we share, we will be giving her a voice and all Afghan women who are living in hell.

I wonder if patients know that their #oncologists also get #scanxiety the day before follow up clinic? We are also desperate to know if you responded to treatment, if you’re in remission, or if we need to have the difficult conversation about what comes next.

Vir Das has touched beautifully upon the two Indias that we have, but there is a third India that he missed out on. (1/n)

nature has actually contacted me for comment about accusations that Sci-Hub is a threat, here is my full response / it is clear that academic publishers care about their money, not about security of other people

AddThis | Home authors.elsevier.com/c/1erEl,V2cW8B…

Locally advanced, high risk low rectal cancer is difficult to treat..glad to share our outcomes with escalated treatment intensity by Induction combination chemotherapy followed by uninterrupted full dose chemotherapy along with long course radiotherapy rdcu.be/dhrz0

“When Less Is Truly More” Excited to share our work from Med Onc CMC Vellore (Official) published in JCO Global Oncology "Does adding low dose Nivo to NACT ⬆️response rates & survival in stage III non-oncogene-driven NSCLC?" 🔗doi.org/10.1200/GO-24-… Mentor Ashish Singh Key findings👇🧵#LCSM

What a mockery we are making of demorcracy. How can a handful of people decide what the large majority of Indians may or may not watch, then go on to enforce that with unrestrained vandalism. I am not a Bhansali fan, but WILL watch padmavati IF IT IS released

What happened in 4 hours is sped to 1 minute. #SuperBlueBloodMoon